Pharmacokinetics and clinical use of cephalosporin antibiotics.
about
Comparative pharmacology of cefaclor and cephalexin.Pharmacokinetics of cefaclor and cephalexin: dosage nomograms for impaired renal function.Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects.Pharmacokinetics of ceforanide in patients with end stage renal disease on hemodialysis.Metabolic fate of SCE-1365, a new broad-spectrum cephalosporin, after parenteral administration to rats and dogsPharmacokinetics of prophylactic cefazolin in parturients undergoing cesarean delivery.Saturation of the tubular excretion of beta-lactam antibiotics.Effect of cephapirin on tubular reabsorption of amino acids, uric acid and beta 2-microglobulin in man.Pharmacokinetics of cefamandole in the presence of renal failure in patients undergoing hemodialysis.Relevance of serum protein binding of cefoxitin and cefazolin to their activities against Klebsiella pneumoniae pneumonia in ratsPharmacokinetics of cefmetazole administered intramuscularly and intravenously to healthy adults.Disposition of carumonam (AMA-1080/Ro 17-2301), a new N-sulfonated monocyclic beta-lactam, in rats and dogsPharmacokinetics of new broad-spectrum cephamycin, YM09330, parenterally administered to various experimental animalsProtein binding of cefazolin is saturable in vivo both between and within patientsTreatment of osteomyelitis and septic arthritis with cefazolin.Metabolic fate of SCE-129, a new antipseudomonal cephalosporin, after parenteral administration in rats and dogsCefazolin and enterobacteriaceae: rationale for revised susceptibility testing breakpoints.Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.Faropenem transport across the renal epithelial luminal membrane via inorganic phosphate transporter Npt1.Anion-exchange extraction of cephapirin, cefotaxime, and cefoxitin from serum for liquid chromatography.Absolute bioavailability of cefprozil after oral administration in beagles.Pharmacokinetics of Intraperitoneal Cefalothin and Cefazolin in Patients Being Treated for Peritoneal Dialysis-Associated Peritonitis.Mechanism of action, antimicrobial activity, pharmacology, adverse effects, and clinical efficacy of cefotaxime.The cephalosporin antibiotic agents--I. Considered as a group.Effect of protein binding on the penetration of nonmetabolized cephalosporins into atrial appendage and pericardial fluids in open-heart surgical patients.Pharmacokinetic comparison of cefroxadin (CGP 9000) and cephalexin by simultaneous administration to humans.Evaluation of the Autobac 1 susceptibility testing system in a clinical diagnostic laboratory.Hemodialysis-associated infections: treatment with cephapirin.Pharmacokinetics of cefamandole in infants and children.Bacampicillin, Ampicillin, Cephalothin, and Cephapirin levels in human blood and interstitial fluid.Pharmacokinetics of cefotaxime.Clinical pharmacokinetics and safety of high doses of ceforanide (BL-S786R) and cefazolin.Comparative pharmacokinetics of cefamandole, cephapirin, and cephalothin in healthy subjects and effect of repeated dosing.Pharmacokinetics of high-dose oral cephalosporins.Antibiotic tissue penetration.Fluorimetric assay of cephradine, cephalexin and cephaloglycin.Pharmacokinetics of cefotetan in normal subjects and patients with impaired renal function.Pharmacokinetics of cefotetan (YM09330) in humans.Multiple-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects.A bioequivalence study of six brands of cephalexin.
P2860
Q30449213-2C194B60-63A2-44B6-8902-166B6BFBEB7FQ30450471-E90DD711-EB23-44E3-8CF4-98944C33F03DQ30451388-CA3FEBA4-32A8-40EB-A5F8-C351CE121FECQ33724102-B415D851-8B55-459E-A547-24783D6C7142Q33734228-FAD6CCC6-1833-4EF7-AEFD-EA2A67A20F55Q33797920-09CA1B8B-660B-46AA-A1F2-FD42850ED420Q34418298-701BFED4-3843-432A-8DB9-8998D9653CE8Q34512323-54D33606-8552-4A73-A75A-7240EF199706Q34981192-85BD6B5F-4557-4AC0-B040-137B532492A2Q35572433-BD88E8A1-327F-4C45-83B8-5E5BD0675BBAQ35647488-14DDAE7A-9751-4A5E-801B-309F827663AEQ35650379-B4C207F5-A449-4886-98A7-64F8AC3265B5Q35671131-D256DD74-CF1D-40F8-B330-D95DB65CFFECQ36024418-EC7352DC-85A2-43E0-8DF0-7271F6C69368Q36467536-F5D492F9-16F2-4BB3-A31F-266A612BC21FQ36472185-AA551108-0914-4AC8-9BA9-75AF1B383EEBQ37856088-479BDE3B-9FF5-40C1-8FF9-5B449B00E9CEQ38846048-4B8B750C-87D7-46BE-8F83-A3B352A748B9Q39473044-19EEB4D0-C362-4B99-8BD2-4C22B362D74BQ39856857-24F194BA-5FAC-4E2F-9DE9-B938FC028463Q39875925-71BB6029-FBCB-4787-8609-00BC6E91EB34Q40110478-BA0FCBA0-CFBA-4E2C-8371-9F01DCFF9982Q40134639-AD866E99-EF75-428D-A354-09144D8FCD94Q40189892-86E7FC0E-962D-4449-8DFF-FFDC3C1304C2Q40281833-B15D23E3-F169-4615-8CCD-86FDBCA398D8Q40283049-AB201BAC-22AC-44C5-9139-2D293130B326Q40617230-FB9A198B-3A7A-4A03-88DB-1926CF664595Q40617805-D5A0D2EC-5B20-46C8-8134-08BACE18C62DQ40619070-D4426D8F-9161-4E7D-900A-91852B8469A5Q40620290-D7426324-3573-4C41-8738-DDF1FBA6687FQ40621252-C75F3EBA-B908-4FB6-9D25-20D811CCED39Q40621266-5C93F531-9B37-4A0C-A98B-7A4E56068F85Q40947263-8A0089C1-F0D8-4FBF-B954-56167513EA81Q41566097-17238B81-1964-4E0D-AE26-CC5599EB5A09Q42065748-CEDF28E4-75BC-421C-AFEF-5F427AF858A7Q42073663-6335027C-42F8-43D9-A9FA-390D2B7DC6E5Q42115617-99F0675F-ADBA-4F0F-8D6C-D0AF90FF400FQ42115636-2F376F33-8B89-4699-9452-66C3A6687299Q42158795-857904A2-A592-4B2C-A353-D06360F6F1A0Q44465036-B28E51C5-53A6-411E-B1AE-AEEB22237C0E
P2860
Pharmacokinetics and clinical use of cephalosporin antibiotics.
description
1975 nî lūn-bûn
@nan
1975 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
Pharmacokinetics and clinical use of cephalosporin antibiotics.
@ast
Pharmacokinetics and clinical use of cephalosporin antibiotics.
@en
Pharmacokinetics and clinical use of cephalosporin antibiotics.
@nl
type
label
Pharmacokinetics and clinical use of cephalosporin antibiotics.
@ast
Pharmacokinetics and clinical use of cephalosporin antibiotics.
@en
Pharmacokinetics and clinical use of cephalosporin antibiotics.
@nl
prefLabel
Pharmacokinetics and clinical use of cephalosporin antibiotics.
@ast
Pharmacokinetics and clinical use of cephalosporin antibiotics.
@en
Pharmacokinetics and clinical use of cephalosporin antibiotics.
@nl
P2093
P356
P1476
Pharmacokinetics and clinical use of cephalosporin antibiotics.
@en
P2093
Nightingale CH
Quintiliani R
P304
P356
10.1002/JPS.2600641202
P407
P577
1975-12-01T00:00:00Z